FDA makes acting CBER and CDER leaders permanent on September 10, 2026 Artificial Intelligence Biological Factors CBER CDER CHARGE Syndrome Drug Regulations Karim Mikhail Leadership Michael Davis United States Food and Drug Administration +
FDA Makes CDER and CBER Leadership Permanent While Commissioner Nominee Awaits Senate Confirmation on September 09, 2026 Biological Factors CBER CDER commissioner confirmation Drug Regulations Heidi Overton Karim Mikhail Kyle Diamantas Michael Davis United States Food and Drug Administration +
Prasad ally Szarama exits CBER after 3 weeks as FDA cleanout continues on May 20, 2026 CBER director Karim Mikhail Katherine Szarama leadership shake-up United States Food and Drug Administration Vinay Prasad +